Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06941961
NA

iTBS for Acute Ischemic Stroke After Thrombectomy

Sponsor: Yi Yang

View on ClinicalTrials.gov

Summary

The goal of this randomized, single-blind, parallel-controlled clinical trial is to evaluate the efficacy and safety of intermittent theta burst stimulation (iTBS) as an adjunctive therapy for acute anterior circulation ischemic stroke patients who have undergone successful mechanical thrombectomy (MT). The study population includes adults aged 18-85 with NIHSS scores 5-25 post-MT and eTICI≥2b reperfusion.

Official title: Efficacy and Safety of Intermittent Theta Burst Stimulation in Acute Anterior Circulation Ischemic Stroke Patients Undergoing Mechanical Thrombectomy

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

178

Start Date

2025-04-25

Completion Date

2026-08-01

Last Updated

2025-04-30

Healthy Volunteers

No

Conditions

Interventions

DEVICE

intermittent theta burst stimulation

The iTBS delivered to the ipsilesional primary motor cortex (M1) at 80% resting motor threshold (RMT). Each session consists of 600 pulses (3-minute trains of 50 Hz triplets repeated every 10 seconds, twice daily with a 5-minute interval), administered for 7 consecutive days starting within 6 hours post-randomization.

DEVICE

sham intermittent theta burst stimulation

Sham-iTBS is performed in the same way as the treatment group but uses 20% RMT.

Locations (1)

The First Hospital of Jilin University

Changchun, Jilin, China